Microbial metabolism linked to insulin resistance

Shimona Starling

DOI: https://doi.org/10.1038/s41574-023-00903-7

2023-09-12

Nature Reviews Endocrinology

Abstract:A new study in Nature has used a comprehensive multi-omics strategy in humans to uncover mechanisms by which carbohydrate metabolism by the gut microbiota contributes to insulin resistance.

endocrinology & metabolism

What problem does this paper attempt to address?

Microbial stars: shedding light on gut microbes' role in insulin resistance and innovative diabetes therapies

Jinwei Zhang

DOI: https://doi.org/10.1080/19490976.2024.2307581

IF: 12.2

2024-01-28

Gut Microbes

Abstract:The role of gut microbiota in insulin resistance (IR), Metabolic Syndrome (MetS), and Type 2 Diabetes Mellitus (T2DM) is rapidly gaining recognition. However, the mechanisms and implications of gut bacteria in these conditions remain enigmatic. This commentary not only highlights the findings of a recent multi-omics study by Takeuchi et al. but also offers a unique perspective by integrating personal opinions and insights. The discussion revolves around the intricate connection between gut microbes and IR, suggesting novel therapeutic potential in targeting gut microbial carbohydrate metabolism for improved IR management and metabolic health.

gastroenterology & hepatology,microbiology
Gut microbial carbohydrate metabolism contributes to insulin resistance

Tadashi Takeuchi,Tetsuya Kubota,Yumiko Nakanishi,Hiroshi Tsugawa,Wataru Suda,Andrew Tae-Jun Kwon,Junshi Yazaki,Kazutaka Ikeda,Shino Nemoto,Yoshiki Mochizuki,Toshimori Kitami,Katsuyuki Yugi,Yoshiko Mizuno,Nobutake Yamamichi,Tsutomu Yamazaki,Iseki Takamoto,Naoto Kubota,Takashi Kadowaki,Erik Arner,Piero Carninci,Osamu Ohara,Makoto Arita,Masahira Hattori,Shigeo Koyasu,Hiroshi Ohno

DOI: https://doi.org/10.1038/s41586-023-06466-x

IF: 64.8

2023-08-30

Nature

Abstract:Abstract Insulin resistance is the primary pathophysiology underlying metabolic syndrome and type 2 diabetes 1,2 . Previous metagenomic studies have described the characteristics of gut microbiota and their roles in metabolizing major nutrients in insulin resistance 3–9 . In particular, carbohydrate metabolism of commensals has been proposed to contribute up to 10% of the host’s overall energy extraction 10 , thereby playing a role in the pathogenesis of obesity and prediabetes 3,4,6 . Nevertheless, the underlying mechanism remains unclear. Here we investigate this relationship using a comprehensive multi-omics strategy in humans. We combine unbiased faecal metabolomics with metagenomics, host metabolomics and transcriptomics data to profile the involvement of the microbiome in insulin resistance. These data reveal that faecal carbohydrates, particularly host-accessible monosaccharides, are increased in individuals with insulin resistance and are associated with microbial carbohydrate metabolisms and host inflammatory cytokines. We identify gut bacteria associated with insulin resistance and insulin sensitivity that show a distinct pattern of carbohydrate metabolism, and demonstrate that insulin-sensitivity-associated bacteria ameliorate host phenotypes of insulin resistance in a mouse model. Our study, which provides a comprehensive view of the host–microorganism relationships in insulin resistance, reveals the impact of carbohydrate metabolism by microbiota, suggesting a potential therapeutic target for ameliorating insulin resistance.

multidisciplinary sciences
Mechanisms linking gut microbial metabolites to insulin resistance

Hye Rim Jang,Hui-Young Lee

DOI: https://doi.org/10.4239/wjd.v12.i6.730

2021-06-15

World Journal of Diabetes

Abstract:Insulin resistance is the rate-limiting step in the development of metabolic diseases, including type 2 diabetes. The gut microbiota has been implicated in host energy metabolism and metabolic diseases and is recognized as a quantitatively important organelle in host metabolism, as the human gut harbors 10 trillion bacterial cells. Gut microbiota break down various nutrients and produce metabolites that play fundamental roles in host metabolism and aid in the identification of possible therapeutic targets for metabolic diseases. Therefore, understanding the various effects of bacterial metabolites in the development of insulin resistance is critical. Here, we review the mechanisms linking gut microbial metabolites to insulin resistance in various insulin-responsive tissues.

endocrinology & metabolism
Synergistic Interplay of Diet, Gut Microbiota, and Insulin Resistance: Unraveling the Molecular Nexus

Rajesh Kanna Gopal,Pitchaipillai Sankar Ganesh,Naji Naseef Pathoor

DOI: https://doi.org/10.1002/mnfr.202400677

2024-11-16

Abstract:This comprehensive review explores the intricate relationship between gut microbiota, diet, and insulin resistance, emphasizing the novel roles of diet-induced microbial changes in influencing metabolic health. It highlights how diet significantly influences gut microbiota composition, with different dietary patterns fostering diverse microbial communities. These diet-induced changes in the microbiome impact human metabolism by affecting inflammation, energy balance, and insulin sensitivity, particularly through microbial metabolites like short-chain fatty acids (SCFAs). Focusing the key mediators like endotoxemia and systemic inflammation, and introduces personalized microbiome-based therapeutic strategies, it also investigates the effects of dietary components-fiber, polyphenols, and lipids-on microbiota and insulin sensitivity, along with the roles of protein intake and amino acid metabolism. The study compares the effects of Western and Mediterranean diets on the microbiota-insulin resistance axis. Therapeutic implications, including probiotics, fecal microbiota transplantation (FMT), and personalized diets, are discussed. Key findings reveal that high-fat diets, especially those rich in saturated fats, contribute to dysbiosis and increased intestinal permeability, while high-fiber diets promote beneficial bacteria and SCFAs. The review underscores the future potential of food and microbiota interventions for preventing or managing insulin resistance.
Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism

Anna Castells-Nobau,José Maria Moreno-Navarrete,Lisset de la Vega-Correa,Irene Puig,Massimo Federici,Jiuwen Sun,Remy Burcelin,Laurence Guzylack-Piriou,Pierre Gourdy,Laurent Cazals,María Arnoriaga-Rodríguez,Gema Frühbeck,Luisa Maria Seoane,José López-Miranda,Francisco J Tinahones,Carlos Dieguez,Marc-Emmanuel Dumas,Vicente Pérez-Brocal,Andrés Moya,Nikolaos Perakakis,Geltrude Mingrone,Stefan Bornstein,Jose Ignacio Rodriguez Hermosa,Ernesto Castro,Jose Manuel Fernández-Real,Jordi Mayneris-Perxachs

DOI: https://doi.org/10.1136/gutjnl-2024-332602

IF: 24.5

2024-10-02

Gut

Abstract:Background: The microbiota is emerging as a key factor in the predisposition to insulin resistance and obesity. Objective: To understand the interplay among gut microbiota and insulin sensitivity in multiple tissues. Design: Integrative multiomics and multitissue approach across six studies, combining euglycaemic clamp measurements (used in four of the six studies) with other measurements of glucose metabolism and insulin resistance (glycated haemoglobin (HbA1c) and fasting glucose). Results: Several genera and species from the Proteobacteria phylum were consistently negatively associated with insulin sensitivity in four studies (ADIPOINST, n=15; IRONMET, n=121, FLORINASH, n=67 and FLOROMIDIA, n=24). Transcriptomic analysis of the jejunum, ileum and colon revealed T cell-related signatures positively linked to insulin sensitivity. Proteobacteria in the ileum and colon were positively associated with HbA1c but negatively with the number of T cells. Jejunal deoxycholic acid was negatively associated with insulin sensitivity. Transcriptomics of subcutaneous adipose tissue (ADIPOMIT, n=740) and visceral adipose tissue (VAT) (ADIPOINST, n=29) revealed T cell-related signatures linked to HbA1c and insulin sensitivity, respectively. VAT Proteobacteria were negatively associated with insulin sensitivity. Multiomics and multitissue integration in the ADIPOINST and FLORINASH studies linked faecal Proteobacteria with jejunal and liver deoxycholic acid, as well as jejunal, VAT and liver transcriptomic signatures involved in the actin cytoskeleton, insulin and T cell signalling. Fasting glucose was consistently linked to interferon-induced genes and antiviral responses in the intestine and VAT. Studies in Drosophila melanogaster validated these human insulin sensitivity-associated changes. Conclusion: These data provide comprehensive insights into the microbiome-gut-adipose-liver axis and its impact on systemic insulin action, suggesting potential therapeutic targets.Cite Now.
Microbial Regulation of Glucose Metabolism and Insulin Resistance

Silke Crommen,Marie-Christine Simon

DOI: https://doi.org/10.3390/genes9010010

IF: 4.141

2017-12-29

Genes

Abstract:Type 2 diabetes is a combined disease, resulting from a hyperglycemia and peripheral and hepatic insulin resistance. Recent data suggest that the gut microbiota is involved in diabetes development, altering metabolic processes including glucose and fatty acid metabolism. Thus, type 2 diabetes patients show a microbial dysbiosis, with reduced butyrate-producing bacteria and elevated potential pathogens compared to metabolically healthy individuals. Furthermore, probiotics are a known tool to modulate the microbiota, having a therapeutic potential. Current literature will be discussed to elucidate the complex interaction of gut microbiota, intestinal permeability and inflammation leading to peripheral and hepatic insulin resistance. Therefore, this review aims to generate a deeper understanding of the underlying mechanism of potential microbial strains, which can be used as probiotics.

genetics & heredity
Screening potential biomarkers associated with insulin resistance in high-fat diet-fed mice by integrating metagenomics and untargeted metabolomics

Yunyan Zhou,Jiahui Tang,Wei Du,Yong Zhang,Bang-Ce Ye

DOI: https://doi.org/10.1128/spectrum.04094-23

IF: 3.7

2024-02-29

Microbiology Spectrum

Abstract:ABSTRACT Insulin resistance is the primary pathophysiological basis for metabolic syndrome and type 2 diabetes. Gut microbiota and microbiota-derived metabolites are pivotal in insulin resistance. However, identifying the specific microbes and key metabolites with causal roles is a challenging task, and the underlying mechanisms require further exploration. Here, we successfully constructed a model of insulin resistance in mice induced by a high-fat diet (HFD) and screened potential biomarkers associated with insulin resistance by integrating metagenomics and untargeted metabolomics. Our findings showed a significant increase in the abundance of 30 species of Alistipes in HFD mice compared to normal diet (ND) mice, while the abundance of Desulfovibrio and Candidatus Amulumruptor was significantly lower in HFD mice than in ND mice. Non-targeted metabolomics analysis identified 21 insulin resistance-associated metabolites, originating from the microbiota or co-metabolized by both the microbiota and the host. These metabolites were primarily enriched in aromatic amino acid metabolism (tryptophan metabolism, tyrosine metabolism, and phenylalanine metabolism) and arginine biosynthesis. Further analysis revealed a significant association between the three distinct genera and 21 differentiated metabolites in the HFD and ND mice. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of representative genomes from 12 species of the three distinct genera further revealed the functional potential in aromatic amino acid metabolism and arginine biosynthesis. This study lays the groundwork for future investigations into the mechanisms through which the gut microbiota and its metabolites impact insulin resistance. IMPORTANCE In this study, we aim to identify the microbes and metabolites linked to insulin resistance, some of which have not been previously reported in insulin resistance-related studies. This adds a complementary dimension to existing research. Furthermore, we establish a correlation between alterations in the gut microbiota and metabolite levels. These findings serve as a foundation for identifying the causal bacterial species and metabolites. They also offer insights that guide further exploration into the mechanisms through which these factors influence host insulin resistance.

microbiology
Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity

Dilvin Semo,Holger Reinecke,Rinesh Godfrey

DOI: https://doi.org/10.1038/s41392-024-01746-y

IF: 39.3

2024-02-22

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy, Published online: 21 February 2024; doi:10.1038/s41392-024-01746-y Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity

biochemistry & molecular biology,cell biology
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases

Serena Sanna,Natalie R. van Zuydam,Anubha Mahajan,Alexander Kurilshikov,Arnau Vich Vila,Urmo Võsa,Zlatan Mujagic,Ad A. M. Masclee,Daisy M. A. E. Jonkers,Marije Oosting,Leo A. B. Joosten,Mihai G. Netea,Lude Franke,Alexandra Zhernakova,Jingyuan Fu,Cisca Wijmenga,Mark I. McCarthy

DOI: https://doi.org/10.1038/s41588-019-0350-x

IF: 30.8

2019-02-18

Nature Genetics

Abstract:Microbiome-wide association studies on large population cohorts have highlighted associations between the gut microbiome and complex traits, including type 2 diabetes (T2D) and obesity1. However, the causal relationships remain largely unresolved. We leveraged information from 952 normoglycemic individuals for whom genome-wide genotyping, gut metagenomic sequence and fecal short-chain fatty acid (SCFA) levels were available2, then combined this information with genome-wide-association summary statistics for 17 metabolic and anthropometric traits. Using bidirectional Mendelian randomization (MR) analyses to assess causality3, we found that the host-genetic-driven increase in gut production of the SCFA butyrate was associated with improved insulin response after an oral glucose-tolerance test (P = 9.8 × 10−5), whereas abnormalities in the production or absorption of another SCFA, propionate, were causally related to an increased risk of T2D (P = 0.004). These data provide evidence of a causal effect of the gut microbiome on metabolic traits and support the use of MR as a means to elucidate causal relationships from microbiome-wide association findings.

genetics & heredity
Gut microbiota in insulin resistance: a bibliometric analysis

Weiwei Tian,Li Liu,Ruirui Wang,Yunyun Quan,Bihua Tang,Dongmei Yu,Lei Zhang,Hua Hua,Junning Zhao

DOI: https://doi.org/10.1007/s40200-023-01342-x

2024-02-14

Abstract:Background: Insulin resistance (IR) is considered the pathogenic driver of diabetes, and can lead to obesity, hypertension, coronary artery disease, metabolic syndrome, and other metabolic disorders. Accumulating evidence indicates that the connection between gut microbiota and IR. This bibliometric analysis aimed to summarize the knowledge structure of gut microbiota in IR. Methods: Articles and reviews related to gut microbiota in IR from 2013 to 2022 were retrieved from the Web of Science Core Collection (WoSCC), and the bibliometric analysis and visualization were performed by Microsoft Excel, Origin, R package (bibliometrix), Citespace, and VOSviewer. Results: A total of 4 749 publications from WoSCC were retrieved, including 3 050 articles and 1 699 reviews. The majority of publications were from China and USA. The University Copenhagen and Shanghai Jiao Tong University were the most active institutions. The journal of Nutrients published the most papers, while Nature was the top 1 co-cited journal, and the major area of these publications was molecular, biology, and immunology. Nieuwdorp M published the highest number of papers, and Cani PD had the highest co-citations. Keyword analysis showed that the most frequently occurring keywords were "gut microbiota", "insulin-resistance", "obesity", and "inflammation". Trend topics and thematic maps showed that serum metabolome and natural products, such as resveratrol, flavonoids were the research hotspots in this field. Conclusion: This bibliometric analysis summarised the hotspots, frontiers, pathogenesis, and treatment strategies, providing a clear and comprehensive profile of gut microbiota in IR. Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01342-x.
Microbiota and diabetes: an evolving relationship

Herbert Tilg,Alexander R Moschen

DOI: https://doi.org/10.1136/gutjnl-2014-306928

IF: 24.5

Gut

Abstract:The gut microbiota affects numerous biological functions throughout the body and its characterisation has become a major research area in biomedicine. Recent studies have suggested that gut bacteria play a fundamental role in diseases such as obesity, diabetes and cardiovascular disease. Data are accumulating in animal models and humans suggesting that obesity and type 2 diabetes (T2D) are associated with a profound dysbiosis. First human metagenome-wide association studies demonstrated highly significant correlations of specific intestinal bacteria, certain bacterial genes and respective metabolic pathways with T2D. Importantly, especially butyrate-producing bacteria such as Roseburia intestinalis and Faecalibacterium prausnitzii concentrations were lower in T2D subjects. This supports the increasing evidence, that butyrate and other short-chain fatty acids are able to exert profound immunometabolic effects. Endotoxaemia, most likely gut-derived has also been observed in patients with metabolic syndrome and T2D and might play a key role in metabolic inflammation. A further hint towards an association between microbiota and T2D has been derived from studies in pregnancy showing that major gut microbial shifts occurring during pregnancy affect host metabolism. Interestingly, certain antidiabetic drugs such as metformin also interfere with the intestinal microbiota. Specific members of the microbiota such as Akkermansia muciniphila might be decreased in diabetes and when administered to murines exerted antidiabetic effects. Therefore, as a 'gut signature' becomes more evident in T2D, a better understanding of the role of the microbiota in diabetes might provide new aspects regarding its pathophysiological relevance and pave the way for new therapeutic principles.
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1

Ara Koh,Antonio Molinaro,Marcus Ståhlman,Muhammad Tanweer Khan,Caroline Schmidt,Louise Mannerås-Holm,Hao Wu,Alba Carreras,Heeyoon Jeong,Louise E. Olofsson,Per-Olof Bergh,Victor Gerdes,Annick Hartstra,Maurits de Brauw,Rosie Perkins,Max Nieuwdorp,Göran Bergström,Fredrik Bäckhed

DOI: https://doi.org/10.1016/j.cell.2018.09.055

IF: 64.5

2018-11-01

Cell

Abstract:SummaryInteractions between the gut microbiota, diet, and the host potentially contribute to the development of metabolic diseases. Here, we identify imidazole propionate as a microbially produced histidine-derived metabolite that is present at higher concentrations in subjects with versus without type 2 diabetes. We show that imidazole propionate is produced from histidine in a gut simulator at higher concentrations when using fecal microbiota from subjects with versus without type 2 diabetes and that it impairs glucose tolerance when administered to mice. We further show that imidazole propionate impairs insulin signaling at the level of insulin receptor substrate through the activation of p38γ MAPK, which promotes p62 phosphorylation and, subsequently, activation of mechanistic target of rapamycin complex 1 (mTORC1). We also demonstrate increased activation of p62 and mTORC1 in liver from subjects with type 2 diabetes. Our findings indicate that the microbial metabolite imidazole propionate may contribute to the pathogenesis of type 2 diabetes.

cell biology,biochemistry & molecular biology
High-Resolution Taxonomic Characterization Reveals Novel Human Microbial Strains with Potential as Risk Factors and Probiotics for Prediabetes and Type 2 Diabetes

Sarah A Hendricks,Chantal A Vella,Daniel D New,Afiya Aunjum,Maximilian Antush,Rayme Geidl,Kimberly R Andrews,Onesmo B Balemba

DOI: https://doi.org/10.3390/microorganisms11030758

IF: 4.5

2023-03-15

Microorganisms

Abstract:Alterations in the composition of the gut microbiota is thought to play a key role in causing type 2 diabetes, yet is not fully understood, especially at the strain level. Here, we used long-read DNA sequencing technology of 16S-ITS-23S rRNA genes for high-resolution characterization of gut microbiota in the development of type 2 diabetes. Gut microbiota composition was characterized from fecal DNA from 47 participants divided into 4 cohorts based on glycemic control: normal glycemic control (healthy; n = 21), reversed prediabetes (prediabetes/healthy; n = 8), prediabetes (n = 8), or type 2 diabetes (n = 10). A total of 46 taxa were found to be possibly related to progression from healthy state to type 2 diabetes. Bacteroides coprophilus DSM 18228, Bifidobacterium pseudocatenulatum DSM 20438, and Bifidobacterium adolescentis ATCC 15703 could confer resistance to glucose intolerance. On the other hand, Odoribacter laneus YIT 12061 may be pathogenic as it was found to be more abundant in type 2 diabetes participants than other cohorts. This research increases our understanding of the structural modulation of gut microbiota in the pathogenesis of type 2 diabetes and highlights gut microbiota strains, with the potential for targeted opportunistic pathogen control or consideration for probiotic prophylaxis and treatment.
Global trends and collaborative networks in gut microbiota-insulin resistance research: a comprehensive bibliometric analysis (2000-2024)

Gulshara Zh Abildinova,Valeriy V Benberin,Tamara A Vochshenkova,Alireza Afshar,Nadiar M Mussin,Asset A Kaliyev,Zhanna Zhussupova,Amin Tamadon

DOI: https://doi.org/10.3389/fmed.2024.1452227

2024-08-15

Abstract:Background: The human gut microbiota plays a crucial role in maintaining metabolic health, with substantial evidence linking its composition to insulin resistance. This study aims to analyze the global scholarly contributions on the relationship between intestinal microbiota and insulin resistance from 2000 to 2024. Methods: A bibliometric analysis was conducted using data from Scopus and Web of Science Core Collection. The search strategy included terms related to "Gastrointestinal Microbiome" and "Insulin Resistance" in the title or abstract. Results: The analysis of 1,884 relevant studies from 510 sources was conducted, revealing a mean citation of 51.36 per manuscript and a remarkable annual growth rate of 22.08%. The findings highlight the significant role of gut microbiota in insulin resistance, corroborating prior studies that emphasize its influence on metabolic disorders. The literature review of the current study showed key mechanisms include the regulation of short-chain fatty acids (SCFAs) and gut hormones, which are critical for glucose metabolism and inflammation regulation. The analysis also identifies "Food and Function" as the most productive journal and Nieuwdorp M. as a leading author, underscoring the collaborative nature of this research area. Conclusion: The consistent increase in publications in the field of gut microbiota and insulin resistance indicates growing recognition of the gut microbiota's therapeutic potential in treating insulin resistance and related metabolic disorders. Future research should focus on standardizing methodologies and conducting large-scale clinical trials to fully realize these therapeutic possibilities.
Gut microbiota impairs insulin clearance in obese mice

Kevin P Foley,Soumaya Zlitni,Brittany M Duggan,Nicole G Barra,Fernando F Anhê,Joseph F Cavallari,Brandyn D Henriksbo,Cassandra Y Chen,Michael Huang,Trevor C Lau,Roxanne Plante,Michael Schwab,André Marette,Jonathan D Schertzer

DOI: https://doi.org/10.1016/j.molmet.2020.101067

Abstract:Objective: Hyperinsulinemia can be both a cause and consequence of obesity and insulin resistance. Hyperinsulinemia can result from increased insulin secretion and/or reduced insulin clearance. While many studies have focused on mechanisms triggering insulin secretion during obesity, the triggers for changes in insulin clearance during obesity are less defined. In this study, we investigated the role of the microbiota in regulating insulin clearance during diet-induced obesity. Methods: Blood glucose and insulin clearance were tested in conventional male mice treated with antibiotics and germ-free mice colonized with microbes from mice that were fed a control (chow) diet or an obesogenic high-fat diet (HFD). The composition of the fecal microbiota was analyzed using 16S rRNA sequencing. Results: Short-term HFD feeding and aging did not alter insulin clearance in the mice. Oral antibiotics mitigated impaired blood insulin clearance in the mice fed an HFD for 12 weeks or longer. Germ-free mice colonized with microbes from HFD-fed donor mice had impaired insulin but not C-peptide clearance. Microbe-transmissible insulin clearance impairment was only observed in germ-free mice after more than 6 weeks post-colonization upon HFD feeding. Five bacterial taxa predicted >90% of the variance in insulin clearance. Mechanistically, impaired insulin clearance was associated with lower levels of hepatic Ceacam-1 but increased liver and skeletal muscle insulin-degrading enzyme (IDE) activity. Conclusions: Gut microbes regulate insulin clearance during diet-induced obesity. A small cluster of microbes or their metabolites may be targeted for mitigating defects in insulin clearance and hyperinsulinemia during the progression of obesity and type 2 diabetes.
Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes

Julia H. Kreznar,Mark P. Keller,Lindsay L. Traeger,Mary E. Rabaglia,Kathryn L. Schueler,Donald S. Stapleton,Wen Zhao,Eugenio I. Vivas,Brian S. Yandell,Aimee Teo Broman,Bruno Hagenbuch,Alan D. Attie,Federico E. Rey

DOI: https://doi.org/10.1016/j.celrep.2017.01.062

IF: 8.8

2017-02-01

Cell Reports

Abstract:Genetic variation drives phenotypic diversity and influences the predisposition to metabolic disease. Here, we characterize the metabolic phenotypes of eight genetically distinct inbred mouse strains in response to a high-fat/high-sucrose diet. We found significant variation in diabetes-related phenotypes and gut microbiota composition among the different mouse strains in response to the dietary challenge and identified taxa associated with these traits. Follow-up microbiota transplant experiments showed that altering the composition of the gut microbiota modifies strain-specific susceptibility to diet-induced metabolic disease. Animals harboring microbial communities with enhanced capacity for processing dietary sugars and for generating hydrophobic bile acids showed increased susceptibility to metabolic disease. Notably, differences in glucose-stimulated insulin secretion between different mouse strains were partially recapitulated via gut microbiota transfer. Our results suggest that the gut microbiome contributes to the genetic and phenotypic diversity observed among mouse strains and provide a link between the gut microbiome and insulin secretion.

cell biology
Microbiota: A potential orchestrator of antidiabetic therapy

Bingyao Liu,Linlin Zhang,Hang Yang,Hongting Zheng,Xiaoyu Liao

DOI: https://doi.org/10.3389/fendo.2023.973624

IF: 6.055

2023-01-28

Frontiers in Endocrinology

Abstract:The gut microbiota, as a 'new organ' of humans, has been identified to affect many biological processes, including immunity, inflammatory response, gut-brain neural circuits, and energy metabolism. Profound dysbiosis of the gut microbiome could change the metabolic pattern, aggravate systemic inflammation and insulin resistance, and exacerbate metabolic disturbance and the progression of type 2 diabetes (T2D). The aim of this review is to focus on the potential roles and functional mechanisms of gut microbiota in the antidiabetic therapy. In general, antidiabetic drugs (α-glucosidase inhibitor, biguanides, incretin-based agents, and traditional Chinese medicine) induce the alteration of microbial diversity and composition, and the levels of bacterial component and derived metabolites, such as lipopolysaccharide (LPS), short chain fatty acids (SCFAs), bile acids and indoles. The altered microbial metabolites are involved in the regulation of gut barrier, inflammation response, insulin resistance and glucose homeostasis. Furthermore, we summarize the new strategies for antidiabetic treatment based on microbial regulation, such as pro/prebiotics administration and fecal microbiota transplantation, and discuss the need for more basic and clinical researches to evaluate the feasibility and efficacy of the new therapies for diabetes.

endocrinology & metabolism
Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment

Bouchra Ezzamouri,Bouchra Ezzamouri,Dorines Rosario,Gholamreza Bidkhori,Gholamreza Bidkhori,Sunjae Lee,Mathias Uhlen,Saeed Shoaie,Saeed Shoaie

DOI: https://doi.org/10.1038/s41540-022-00261-6

2023-01-21

npj Systems Biology and Applications

Abstract:The human gut microbiome has been associated with several metabolic disorders including type 2 diabetes mellitus. Understanding metabolic changes in the gut microbiome is important to elucidate the role of gut bacteria in regulating host metabolism. Here, we used available metagenomics data from a metformin study, together with genome-scale metabolic modelling of the key bacteria in individual and community-level to investigate the mechanistic role of the gut microbiome in response to metformin. Individual modelling predicted that species that are increased after metformin treatment have higher growth rates in comparison to species that are decreased after metformin treatment. Gut microbial enrichment analysis showed prior to metformin treatment pathways related to the hypoglycemic effect were enriched. Our observations highlight how the key bacterial species after metformin treatment have commensal and competing behavior, and how their cellular metabolism changes due to different nutritional environment. Integrating different diets showed there were specific microbial alterations between different diets. These results show the importance of the nutritional environment and how dietary guidelines may improve drug efficiency through the gut microbiota.

mathematical & computational biology
Resistant starch can improve insulin sensitivity independently of the gut microbiota

Laure B. Bindels,Rafael R. Segura Munoz,João Carlos Gomes-Neto,Valentin Mutemberezi,Inés Martínez,Nuria Salazar,Elizabeth A. Cody,Maria I. Quintero-Villegas,Hatem Kittana,Clara G de los Reyes-Gavilán,Robert J. Schmaltz,Giulio G. Muccioli,Jens Walter,Amanda E. Ramer-Tait

DOI: https://doi.org/10.1186/s40168-017-0230-5

IF: 15.5

2017-02-07

Microbiome

Abstract:BackgroundObesity-related diseases, including type 2 diabetes and cardiovascular disease, have reached epidemic proportions in industrialized nations, and dietary interventions for their prevention are therefore important. Resistant starches (RS) improve insulin sensitivity in clinical trials, but the mechanisms underlying this health benefit remain poorly understood. Because RS fermentation by the gut microbiota results in the formation of physiologically active metabolites, we chose to specifically determine the role of the gut microbiota in mediating the metabolic benefits of RS. To achieve this goal, we determined the effects of RS when added to a Western diet on host metabolism in mice with and without a microbiota.ResultsRS feeding of conventionalized mice improved insulin sensitivity and redressed some of the Western diet-induced changes in microbiome composition. However, parallel experiments in germ-free littermates revealed that RS-mediated improvements in insulin levels also occurred in the absence of a microbiota. RS reduced gene expression of adipose tissue macrophage markers and altered cecal concentrations of several bile acids in both germ-free and conventionalized mice; these effects were strongly correlated with the metabolic benefits, providing a potential microbiota-independent mechanism to explain the physiological effects of RS.ConclusionsThis study demonstrated that some metabolic benefits exerted by dietary RS, especially improvements in insulin levels, occur independently of the microbiota and could involve alterations in the bile acid cycle and adipose tissue immune modulation. This work also sets a precedent for future mechanistic studies aimed at establishing the causative role of the gut microbiota in mediating the benefits of bioactive compounds and functional foods.

microbiology
Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes

Zhendong Mei,Fenglei Wang,Amrisha Bhosle,Danyue Dong,Raaj Mehta,Andrew Ghazi,Yancong Zhang,Yuxi Liu,Ehud Rinott,Siyuan Ma,Eric B. Rimm,Martha Daviglus,Walter C. Willett,Rob Knight,Frank B. Hu,Qibin Qi,Andrew T. Chan,Robert D. Burk,Meir J. Stampfer,Iris Shai,Robert C. Kaplan,Curtis Huttenhower,Dong D. Wang

DOI: https://doi.org/10.1038/s41591-024-03067-7

IF: 82.9

2024-06-26

Nature Medicine

Abstract:The association of gut microbial features with type 2 diabetes (T2D) has been inconsistent due in part to the complexity of this disease and variation in study design. Even in cases in which individual microbial species have been associated with T2D, mechanisms have been unable to be attributed to these associations based on specific microbial strains. We conducted a comprehensive study of the T2D microbiome, analyzing 8,117 shotgun metagenomes from 10 cohorts of individuals with T2D, prediabetes, and normoglycemic status in the United States, Europe, Israel and China. Dysbiosis in 19 phylogenetically diverse species was associated with T2D (false discovery rate < 0.10), for example, enriched Clostridium bolteae and depleted Butyrivibrio crossotus . These microorganisms also contributed to community-level functional changes potentially underlying T2D pathogenesis, for example, perturbations in glucose metabolism. Our study identifies within-species phylogenetic diversity for strains of 27 species that explain inter-individual differences in T2D risk, such as Eubacterium rectale . In some cases, these were explained by strain-specific gene carriage, including loci involved in various mechanisms of horizontal gene transfer and novel biological processes underlying metabolic risk, for example, quorum sensing. In summary, our study provides robust cross-cohort microbial signatures in a strain-resolved manner and offers new mechanistic insights into T2D.

biochemistry & molecular biology,cell biology,medicine, research & experimental

Microbial metabolism linked to insulin resistance

Microbial stars: shedding light on gut microbes' role in insulin resistance and innovative diabetes therapies

Gut microbial carbohydrate metabolism contributes to insulin resistance

Mechanisms linking gut microbial metabolites to insulin resistance

Synergistic Interplay of Diet, Gut Microbiota, and Insulin Resistance: Unraveling the Molecular Nexus

Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism

Microbial Regulation of Glucose Metabolism and Insulin Resistance

Screening potential biomarkers associated with insulin resistance in high-fat diet-fed mice by integrating metagenomics and untargeted metabolomics

Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases

Gut microbiota in insulin resistance: a bibliometric analysis

Microbiota and diabetes: an evolving relationship

Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1

High-Resolution Taxonomic Characterization Reveals Novel Human Microbial Strains with Potential as Risk Factors and Probiotics for Prediabetes and Type 2 Diabetes

Global trends and collaborative networks in gut microbiota-insulin resistance research: a comprehensive bibliometric analysis (2000-2024)

Gut microbiota impairs insulin clearance in obese mice

Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes

Microbiota: A potential orchestrator of antidiabetic therapy

Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment

Resistant starch can improve insulin sensitivity independently of the gut microbiota

Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes